Phase 2 Frontotemporal Dementia, Behavioral Variant Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia
fronto-temporal dementiaFrontotemporal DementiaFrontotemporal Degeneration+3 more
Johns Hopkins University50 enrolled1 locationNCT06604520
Recruiting
Phase 2
Nabilone for Agitation in Frontotemporal Dementia
Frontotemporal DementiaPrimary Progressive AphasiaFTD+3 more
Simon Ducharme, MD45 enrolled7 locationsNCT05742698